Carmell Co. (NASDAQ:CTCX) Sees Significant Growth in Short Interest

Carmell Co. (NASDAQ:CTCXGet Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totalling 39,400 shares, a growth of 11.0% from the May 31st total of 35,500 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average daily volume of 11,100 shares, the days-to-cover ratio is currently 3.5 days.

Carmell Price Performance

Shares of CTCX traded up $0.31 during midday trading on Monday, reaching $1.64. The stock had a trading volume of 33,076 shares, compared to its average volume of 9,080. Carmell has a 1-year low of $1.11 and a 1-year high of $13.31. The company’s fifty day simple moving average is $2.10 and its two-hundred day simple moving average is $2.79.

Carmell (NASDAQ:CTCXGet Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.16) earnings per share for the quarter.

Institutional Investors Weigh In On Carmell

A hedge fund recently bought a new stake in Carmell stock. Hubbell Strickland Wealth Management LLC purchased a new position in shares of Carmell Co. (NASDAQ:CTCXFree Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 12,548 shares of the company’s stock, valued at approximately $32,000. Hubbell Strickland Wealth Management LLC owned approximately 0.07% of Carmell at the end of the most recent reporting period. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Carmell

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

See Also

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.